DIMENSIONAL FUND ADVISORS LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$2,725,306
-75.1%
801,603
-46.2%
0.00%
-66.7%
Q2 2023$10,949,156
-41.6%
1,489,585
-17.7%
0.00%
-50.0%
Q1 2023$18,760,883
+86272.1%
1,810,929
-1.5%
0.01%0.0%
Q4 2022$21,721
-99.9%
1,839,161
-4.3%
0.01%
-60.0%
Q3 2022$40,348,000
-33.2%
1,922,230
-1.3%
0.02%
-31.8%
Q2 2022$60,443,000
+7.6%
1,947,332
+42.3%
0.02%
+29.4%
Q1 2022$56,199,000
+26.0%
1,368,661
+33.4%
0.02%
+30.8%
Q4 2021$44,590,000
-9.7%
1,025,697
+4.0%
0.01%
-18.8%
Q3 2021$49,401,000
-19.6%
986,560
+1.1%
0.02%
-15.8%
Q2 2021$61,470,000
-36.9%
975,838
-7.0%
0.02%
-40.6%
Q1 2021$97,461,000
+4.9%
1,049,045
+1.2%
0.03%
-5.9%
Q4 2020$92,906,000
-23.2%
1,036,814
-11.5%
0.03%
-33.3%
Q3 2020$121,036,000
+22.6%
1,171,334
-6.2%
0.05%
+18.6%
Q2 2020$98,738,000
+34.8%
1,248,712
-1.3%
0.04%
+13.2%
Q1 2020$73,231,000
+3.5%
1,265,790
-3.5%
0.04%
+46.2%
Q4 2019$70,756,000
-9.7%
1,311,500
-12.5%
0.03%
-13.3%
Q3 2019$78,352,000
-1.0%
1,498,749
-8.5%
0.03%
-3.2%
Q2 2019$79,156,000
-1.6%
1,638,499
+2.9%
0.03%
-3.1%
Q1 2019$80,467,000
-19.7%
1,592,790
-5.7%
0.03%
-28.9%
Q4 2018$100,167,000
-12.9%
1,689,740
-3.3%
0.04%
+2.3%
Q3 2018$115,059,000
+11.9%
1,747,821
-14.2%
0.04%
+7.3%
Q2 2018$102,813,000
-11.5%
2,036,284
-7.7%
0.04%
-14.6%
Q1 2018$116,123,000
+11.2%
2,205,564
-1.8%
0.05%
+11.6%
Q4 2017$104,400,000
+16.0%
2,246,550
+1.0%
0.04%
+10.3%
Q3 2017$89,968,000
+20.3%
2,224,198
+0.8%
0.04%
+11.4%
Q2 2017$74,795,000
+25.4%
2,205,712
+7.4%
0.04%
+20.7%
Q1 2017$59,639,000
-10.3%
2,053,683
+1.4%
0.03%
-12.1%
Q4 2016$66,512,000
+3.1%
2,025,318
-1.0%
0.03%
-5.7%
Q3 2016$64,514,000
+6.7%
2,046,250
-4.8%
0.04%0.0%
Q2 2016$60,453,000
-19.3%
2,149,815
+4.3%
0.04%
-22.2%
Q1 2016$74,943,000
-2.0%
2,061,744
+7.9%
0.04%
-6.2%
Q4 2015$76,485,000
+49.2%
1,911,645
+6.3%
0.05%
+41.2%
Q3 2015$51,260,000
-9.1%
1,799,193
+5.2%
0.03%
-2.9%
Q2 2015$56,364,000
+22.8%
1,710,650
+7.2%
0.04%
+20.7%
Q1 2015$45,897,000
+12.3%
1,595,862
+6.3%
0.03%
+7.4%
Q4 2014$40,877,000
+29.3%
1,501,159
+1.2%
0.03%
+22.7%
Q3 2014$31,613,000
-4.6%
1,483,417
+0.5%
0.02%
-4.3%
Q2 2014$33,153,000
+2.6%
1,476,073
+15.5%
0.02%
-4.2%
Q1 2014$32,306,000
+18.6%
1,278,440
+7.9%
0.02%
+14.3%
Q4 2013$27,230,000
+31.8%
1,184,393
+9.2%
0.02%
+16.7%
Q3 2013$20,660,000
+36.3%
1,084,546
+3.2%
0.02%
+28.6%
Q2 2013$15,156,0001,051,0560.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders